当前位置:
X-MOL 学术
›
Theranostics
›
论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Tumor-penetrating Peptide Conjugated and Doxorubicin Loaded T1-T2 Dual Mode MRI Contrast Agents Nanoparticles for Tumor Theranostics
Theranostics ( IF 12.4 ) Pub Date : 2018-01-01 , DOI: 10.7150/thno.21074 Lipeng Gao , Jing Yu , Yang Liu , Jinge Zhou , Lei Sun , Jing Wang , Jianzhong Zhu , Hui Peng , Weiyue Lu , Lei Yu , Zhiqiang Yan , Yiting Wang
Theranostics ( IF 12.4 ) Pub Date : 2018-01-01 , DOI: 10.7150/thno.21074 Lipeng Gao , Jing Yu , Yang Liu , Jinge Zhou , Lei Sun , Jing Wang , Jianzhong Zhu , Hui Peng , Weiyue Lu , Lei Yu , Zhiqiang Yan , Yiting Wang
The conventional chemotherapeutics could not be traced in vivo and provide timely feedback on the clinical effectiveness of drugs.
中文翻译:
肿瘤穿透肽共轭和阿霉素负载的T 1 -T 2双模式MRI造影剂纳米颗粒用于肿瘤治疗。
无法在体内追踪到常规化学疗法,无法及时提供有关药物临床疗效的反馈。
更新日期:2018-01-01
中文翻译:
肿瘤穿透肽共轭和阿霉素负载的T 1 -T 2双模式MRI造影剂纳米颗粒用于肿瘤治疗。
无法在体内追踪到常规化学疗法,无法及时提供有关药物临床疗效的反馈。